Press Release

Inauguration of Dr. Youngmee Jee as the New CEO of the Institut Pasteur Korea

Inauguration of Dr. Youngmee Jee as the New CEO of the Institut Pasteur Korea
- A world-renowned expert in infectious disease research who has served widely in major national and international public health bodies and research institutions -
The Institut Pasteur Korea (hereinafter IPK) announced that Dr. Youngmee Jee was inaugurated as the new CEO as of Jan. 1, 2021. Dr. Jee has been at the forefront of infectious disease research and response, having served as Director-General of the Center for Infectious Disease Research of Korea National Institute of Health (hereinafter KNIH), Korea Centers for Disease Control & Prevention (KCDC), Head of Cross-ministerial Task Force Team for the Forum on Infectious Disease Research and Development (FID), and as President of Korean Society for Infectious Diseases (KSID).
Dr. Youngmee Jee, CEO of the Institut Pasteur Korea
Dr. Jee also worked as regional coordinator of the Expanded Programme on Immunization of the World Health Organization (WHO) Western Pacific Regional Office, where she cooperated with national health and research institutes in member states in East Asia and the Pacific and contributed to strengthening the member states’ capacity of laboratory diagnosis and research.

Currently, Dr. Jee is a member of the Emergency Committee for COVID-19 and of the Scientific Advisory Group for an R&D Blueprint for Action to Prevent Epidemics, and was a member of the WHO Strategic Advisory Group of Experts on Immunization (SAGE). She has also taken on a number of responsibilities in Korea amid the COVID-19 crisis. She is Special Advisor to the Prime Minister on Health Affairs and Special Representative of Health and Diplomacy of the Korea Foundation.

Dr. Jee has substantial experience of working with the IPK. As a member of the Scientific Advisory Committee from 2018 to 2020, Dr. Jee provided scientific advice based on her in-depth understanding of the IPK's research programs and technologies. She also promoted cooperation between the IPK and KNIH in the drug discovery of infectious diseases by holding joint symposiums in 2016 and 2017.

Dr. Jee has expressed her vision and mission as CEO of the IPK in the following terms: “I will lead the Institut Pasteur Korea towards contributing to the overcoming of the COVID-19 crisis by helping to maximize the Institut’s basic, applied and translational research capabilities, which the IPK has demonstrated by way of its achievements including the progress in the development of therapeutics in response to COVID-19, and to strengthen global cooperation as a part of the Institut Pasteur International Network. The IPK will play a leading role in the Asia and global research network on infectious diseases.”

Dr. Yong-Kyung Choe, Chairman of the Board of Directors of the IPK, said, "Thanks to the vision and leadership of the new CEO, Dr. Jee, who has excellent expertise and extensive worldwide experiences in the field of infectious diseases, I expect the IPK to become a pivotal center of global research and response to infectious diseases."